Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.60 |
| ▸ | DPP4 | P27487 | 8/20 | 0.55 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 6/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7189503 | 1.00 | ABCG2 (0.60) | ABCG2DPP4TNFRSF1APTPN1LMNA | |
| SCHEMBL7183664 | 0.87 | ABCG2 (0.59) | ABCG2DPP4TNFRSF1APTPN1 | |
| SCHEMBL7183673 | 0.87 | ABCG2 (0.59) | ABCG2DPP4TNFRSF1APTPN1 | |
| SCHEMBL7184148 | 0.87 | ABCG2 (0.53) | ABCG2DPP4TNFRSF1APTPN1 | |
| SCHEMBL7184141 | 0.87 | ABCG2 (0.53) | ABCG2DPP4TNFRSF1APTPN1 | |
| SCHEMBL9112464 | 0.86 | DPP4 (0.70) | ABCG2DPP4TNFRSF1APTPN1LMNA | |
| SCHEMBL9112466 | 0.86 | DPP4 (0.70) | ABCG2DPP4TNFRSF1APTPN1LMNA | |
| SCHEMBL7184729 | 0.85 | PTPN1 (0.59) | ABCG2DPP4TNFRSF1APTPN1 | |
| SCHEMBL7184724 | 0.85 | PTPN1 (0.59) | ABCG2DPP4TNFRSF1APTPN1 | |
| SCHEMBL7184612 | 0.84 | PTPN1 (0.56) | ABCG2DPP4TNFRSF1APTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6603046-B1 | The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. | LICA PHARMACEUTICALS A/S (DK) | 2003-08-05 | — | — | US | disclosed |
| EP-0634927-B1 | TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA | LICA PHARMACEUTICALS AS (DK) | 2001-07-04 | — | — | EP | disclosed |